190 related articles for article (PubMed ID: 36064814)
1. Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.
Vegezzi E; Cortese A; Bergsland N; Mussinelli R; Paoletti M; Solazzo F; Currò R; Ascagni L; Callegari I; Quartesan I; Lozza A; Deligianni X; Santini F; Marchioni E; Cosentino G; Alfonsi E; Tassorelli C; Bastianello S; Merlini G; Palladini G; Obici L; Pichiecchio A
J Neurol; 2023 Jan; 270(1):328-339. PubMed ID: 36064814
[TBL] [Abstract][Full Text] [Related]
2. Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
Kollmer J; Hegenbart U; Kimmich C; Hund E; Purrucker JC; Hayes JM; Lentz SI; Sam G; Jende JME; Schönland SO; Bendszus M; Heiland S; Weiler M
Ann Clin Transl Neurol; 2020 May; 7(5):799-807. PubMed ID: 32333729
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.
Gasparotti R; Salvalaggio A; Corbo D; Agazzi G; Cacciavillani M; Lozza A; Fenu S; De Vigili G; Tagliapietra M; Fabrizi GM; Pareyson D; Obici L; Briani C
J Neurol; 2023 Oct; 270(10):4827-4840. PubMed ID: 37329346
[TBL] [Abstract][Full Text] [Related]
4. 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy.
Hodel J; Benadjaoud S; Benadjaoud MA; Lefaucheur JP; Planté-Bordeneuve V
Eur Radiol; 2022 Nov; 32(11):7865-7871. PubMed ID: 35438324
[TBL] [Abstract][Full Text] [Related]
5. Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease.
Poncelet A; Weiler M; Hegenbart U; Sam G; Schönland S; Purrucker JC; Hayes JM; Hund E; Bendszus M; Heiland S; Kollmer J
Invest Radiol; 2022 May; 57(5):301-307. PubMed ID: 34839307
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
[TBL] [Abstract][Full Text] [Related]
7. Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Merkel M; Danese D; Chen C; Wang J; Wu A; Yang H; Lin H
Expert Opin Pharmacother; 2023; 24(10):1205-1214. PubMed ID: 37219406
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.
Berends M; Brunger AF; Bijzet J; Kroesen BJ; Drost G; Lange F; Teunissen CE; In 't Veld S; Vrancken AF; Gans ROB; Hazenberg BPC; van der Zwaag PA; Nienhuis HLA
Amyloid; 2024 Jun; 31(2):132-141. PubMed ID: 38477065
[TBL] [Abstract][Full Text] [Related]
9. In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Kollmer J; Hund E; Hornung B; Hegenbart U; Schönland SO; Kimmich C; Kristen AV; Purrucker J; Röcken C; Heiland S; Bendszus M; Pham M
Brain; 2015 Mar; 138(Pt 3):549-62. PubMed ID: 25526974
[TBL] [Abstract][Full Text] [Related]
10. Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study.
Primiano G; Verdolotti T; D'Apolito G; Di Paolantonio A; Guglielmino V; Romano A; Lucioli G; Luigetti M; Servidei S
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828392
[TBL] [Abstract][Full Text] [Related]
11. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
[TBL] [Abstract][Full Text] [Related]
12. Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.
Tan SY; Tan CY; Yahya MA; Low SC; Shahrizaila N; Goh KJ
Neurol Sci; 2024 Jan; ():. PubMed ID: 38270729
[TBL] [Abstract][Full Text] [Related]
13. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
[TBL] [Abstract][Full Text] [Related]
14. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
[TBL] [Abstract][Full Text] [Related]
15. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
17. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
[TBL] [Abstract][Full Text] [Related]
18. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Involvement Pattern of Hereditary Transthyretin Amyloidosis: A Study Based on Muscle MRI.
Chu X; Du K; Tang Y; Zhao X; Yu M; Zheng Y; Deng J; Lv H; Zhang W; Wang Z; Yuan Y; Meng L
Front Neurol; 2022; 13():851190. PubMed ID: 35592471
[TBL] [Abstract][Full Text] [Related]
20. Quantification of muscle involvement in familial amyloid polyneuropathy using MRI.
Durelle C; Delmont E; Michel C; Trabelsi A; Hostin MA; Ogier A; Bendahan D; Attarian S
Eur J Neurol; 2023 Oct; 30(10):3286-3295. PubMed ID: 37422895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
